NCT00784056

CompletedPhase 3

Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Photo Eva...

Sanofi Source

Compare

Other study identifiers

Sponsor study identifier

LACAC_L_04306

Study Type

interventional

Actual enrollment (reported)

26

Locations

1 country

Sites

1

Timeline

Study Start

August 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

September 2008

Actual (reported)

Study Completion

September 2008

Actual (reported)

Brief Summary

The purpose of this study is to demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDETINLYN Tangerine Mix (Lactic Acid).

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 26 participants
Study completion date: September 2008
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
August 2008
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
September 2008
Actual (reported)
Study Completion
September 2008
Actual (reported)
First Submitted
October 31, 2008
Actual (reported)
First Posted
November 3, 2008
Actual (reported)

Last Updated: August 25, 2009
Status Verified: August 2009
Last Update Submitted: August 21, 2009

Conditions

Hygiene

Outcome Measures

Primary Outcomes (2)

The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale.
Throughout the study
The sensibility will be evaluated according to the skin type.
Throughout the study

Study Arms (1)

1

EXPERIMENTAL

Lactic Acid (Dermacyd PH\_DETINLYN Tangerine Mix)

Drug: Lactic Acid (Dermacyd PH_DETINLYN Tangerine Mix)

Interventions

Lactic Acid (Dermacyd PH_DETINLYN Tangerine Mix)Drug

Lactic Acid (Dermacyd PH\_DETINLYN Tangerine Mix)

1

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 60 Years

Sexfemale

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

Age between 18 and 60 years old;
Phototype Skin II and III;

Sponsors & Collaborators

Sanofi
Industrylead

Study Sites (1)

Sanofi-Aventis Administrative Office

São Paulo, Brazil

MeSH Terms

Interventions

Lactic Acid

Intervention Hierarchy (Ancestors)

LactatesHydroxy AcidsCarboxylic AcidsOrganic Chemicals

Study Officials

Jaderson Lima
Sanofi
STUDY DIRECTOR

Enrollment

26 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 3
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: SUPPORTIVE CARE
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY

Study Record Dates

First Submitted

October 31, 2008

First Posted

November 3, 2008

Study Start

August 2008

Date type not reported

This date has not been verified as actual or estimated.

NCT00785590

Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.

Phase 3Completed

NCT00784160

Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid)- Compatibility

Phase 3Completed

NCT00933257

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Photo Evaluation - Stay on Frutal

Phase 3Completed

NCT00933842

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Photo Evaluation - Stay on Floral

Phase 3Completed

NCT00784069

Dermacyd Breeze (Lactic Acid) Pocket BR - Photo Evaluation

Phase 3Completed

NCT00783640

Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation

Phase 3Completed

Integral skin test in the region;

Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

You may not qualify if:

Lactation or gestation
Use of Antiinflammatory and/or immunossupression drugs 15 days before the selection;
Diseases which can cause immunity decrease, such as HIV, diabetes;
Use of drug photosensitizer;
History of sensitivity or irritation for topic products;
Active cutaneous disease which can change the study results;
History of photodermatosis active;
Family or personal antecedent of cutaneous photo induced neoplasias;
Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and queratoses actinium;
Intense solar exposure in the study area;
Use of new drugs or cosmetics during the study;

Contact the study team to confirm eligibility.

Primary Completion

September 2008

Actual (reported)

Study Completion

September 2008

Actual (reported)

Last Updated

August 25, 2009

Record last verified: 2009-08

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00784056
Data provider: ClinicalTrials.gov
Source updated: 2009-08-25
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:38:07 UTC

Locations

BR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (2)

Study Arms (1)

1

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations